MSC EVs in Dystrophic Epidermolysis Bullosa

NCT04173650 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Dystrophic Epidermolysis Bullosa

Interventions

DRUG: AGLE-102

Sponsor

Aegle Therapeutics